HuGE Literature Finder
|
Records 1-5
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients.
Pharmacogenomics 2017 Mar . Allegra Sarah, De Francia Silvia, Cusato Jessica, Arduino Arianna, Massano Davide, Longo Filomena, Piga Antonio, D'Avolio Anton |
Gilbert syndrome redefined: a complex genetic haplotype influences the regulation of glucuronidation.
Hepatology (Baltimore, Md.) 2012 Jun 55 (6): 1912-21. Ehmer Ursula, Kalthoff Sandra, Fakundiny Bastian, Pabst Brigitte, Freiberg Nicole, Naumann Ronald, Manns Michael P, Strassburg Christian |
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.
![]() PloS one 2012 7 (4): e34741. Milton Jacqueline N, Sebastiani Paola, Solovieff Nadia, Hartley Stephen W, Bhatnagar Pallav, Arking Dan E, Dworkis Daniel A, Casella James F, Barron-Casella Emily, Bean Christopher J, Hooper W Craig, DeBaun Michael R, Garrett Melanie E, Soldano Karen, Telen Marilyn J, Ashley-Koch Allison, Gladwin Mark T, Baldwin Clinton T, Steinberg Martin H, Klings Elizabeth |
Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy - An extended haplotype of genetic variants increases risk in indinavir treatment.
Journal of hepatology 2009 Mar . Lankisch TO, Behrens G, Ehmer U, Möbius U, Rockstroh J, Wehmeier M, Kalthoff S, Freiberg N, Manns MP, Schmidt RE, Strassburg CP |
Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.
The British journal of surgery 2008 Apr 95 (4): 499-505. Berkhout M, Roelofs H M J, te Morsche R H M, Dekker E, van Krieken J H J M, Nagengast F M, Peters W H |
- Page last reviewed:Jul 30, 2019
- Page last updated:Dec 12, 2019
- Content source: